Role of Apolipoprotein L1 in Human Parietal Epithelial Cell Transition
- 7 September 2018
- journal article
- research article
- Published by Elsevier BV in The American Journal of Pathology
- Vol. 188 (11), 2508-2528
- https://doi.org/10.1016/j.ajpath.2018.07.025
Abstract
No abstract availableKeywords
Funding Information
- NIH (RO1DK098074, RO1DK118017)
- Israel Science Foundation
- Rambam Medical Center
- Kaylie Kidney Health Center of Excellence
- Beutler Foundation For Genomic Medicine Research
This publication has 39 references indexed in Scilit:
- Focal segmental glomerulosclerosis is induced by microRNA-193a and its downregulation of WT1Nature Medicine, 2013
- APOL1 Null Alleles from a Rural Village in India Do Not Correlate with GlomerulosclerosisPLOS ONE, 2012
- Population-Based Risk Assessment of APOL1 on Renal DiseaseJournal of the American Society of Nephrology, 2011
- APOL1 Genetic Variants in Focal Segmental Glomerulosclerosis and HIV-Associated NephropathyJournal of the American Society of Nephrology, 2011
- APOL1 Localization in Normal Kidney and Nondiabetic Kidney DiseaseJournal of the American Society of Nephrology, 2011
- HIV-Associated Nephropathy: Role of Mammalian Target of Rapamycin PathwayThe American Journal of Pathology, 2010
- Missense mutations in the APOL1 gene are highly associated with end stage kidney disease risk previously attributed to the MYH9 geneHuman Genetics, 2010
- Inhibition of p66ShcA Longevity Gene Rescues Podocytes from HIV-1-induced Oxidative Stress and ApoptosisPublished by Elsevier BV ,2009
- Recruitment of Podocytes from Glomerular Parietal Epithelial CellsJournal of the American Society of Nephrology, 2009
- CellProfiler™: Free, Versatile Software for Automated Biological Image AnalysisBioTechniques, 2007